Feature Channels: All Journal News

Filters close
5-Dec-2019 10:35 AM EST
Too Few Hospitals Have Clinical Decision Support Tools to Calculate Nutrition for Critically Ill Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

Most neonatal intensive care units (NICUs) participating in the Children’s Hospitals Neonatal Consortium are unable to reliably and consistently monitor caloric intake delivered to critically ill infants at risk for growth failure, according to a study published in the Journal of Perinatology. Managing optimal nutrition for preemies is a complex process, especially when the baby is transitioned from receiving nutrition intravenously to enteral (or through the gut) feeds. The study found low prevalence of fully automated clinical decision support systems used to calculate and adjust nutritional intake for premature infants.

5-Dec-2019 12:00 PM EST
A Person’s Perception of Risk Can Tell Us About Their Chances of Opioid Relapse
Rutgers University-New Brunswick

People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.

3-Dec-2019 12:05 PM EST
Computer Game May Help to Predict Reuse of Opioids
NYU Langone Health

A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.

5-Dec-2019 12:05 PM EST
Use of venetoclax in reduced-intensity transplant conditioning regimen in patients with high-risk myeloid cancers shows promise in early trial
Dana-Farber Cancer Institute

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients’ bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

2-Dec-2019 12:00 PM EST
Lymphoma Patients May Have New Path to Remission, Even When CAR T Therapy Fails
Perelman School of Medicine at the University of Pennsylvania

A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission.

Released: 6-Dec-2019 7:05 PM EST
Bing Crosby’s Legacy Alive and Well Here
Gonzaga University

Thousands of fans from 20 countries flock to Crosby House museum in busloads each year.

Released: 6-Dec-2019 7:00 PM EST
Co-addiction of meth and opioids hinders treatment
University of Washington School of Medicine

A study published in the Journal of Substance Abuse Treatment of 799 patients in three locations found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.

Released: 6-Dec-2019 3:05 PM EST
Current treatment for fungal meningitis is fueling drug resistance
University of Liverpool

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Released: 6-Dec-2019 3:05 PM EST
Gulf Coast corals face catastrophe
Rice University

If coral reefs are the canary to the ocean's coal mine, it's getting awfully bleak in the Gulf of Mexico.

Released: 6-Dec-2019 2:25 PM EST
Patient Factors Explain Most of the Variation in Function After Lower Spinal Fusion
Wolters Kluwer Health: Lippincott

Patient-reported functional outcomes vary considerably after lower (lumbar) spinal fusion surgery. But the variability mainly reflects patient characteristics, rather than differences in care provided by surgeons or hospitals, suggests a study in Spine. The journal is published in the Lippincott portfolio by Wolters Kluwer.

6-Dec-2019 8:50 AM EST
New Ultra-Miniaturized Scope Less Invasive, Produces Higher Quality Images
 Johns Hopkins University

Johns Hopkins engineers have created a new lens-free ultra-miniaturized endoscope, the size of a few human hairs in width, that is less bulky and can produce higher quality images.

4-Dec-2019 11:00 AM EST
Little Size Holds Big Impact: Johns Hopkins Scientists Develop Nanocontainer to Ship Titan-Size Gene Therapies And Drugs Into Cells
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size — even hefty ones attached to the gene-editing tool called CRISPR. If their creation – constructed of a biodegradable polymer — passes more laboratory testing, it could offer a way to efficiently ferry larger medical compounds into specifically selected target cells.

Released: 6-Dec-2019 1:05 PM EST
Technique shows how individual cancer cells react to drugs
University of Washington School of Medicine

A new technique reported in Science offers more detail, at the single cell level, on how large, pooled samples of various cells react to drugs or other agents. The data might reveal mode of action or the effect of genetic differences in varying responses.

Released: 6-Dec-2019 12:45 PM EST
Yervant Terzian, who explored matter between stars, dies at 80
Cornell University

Yervant Terzian, the Tisch Distinguished Professor Emeritus in the Department of Astronomy at Cornell University, who studied the physical matter between stars, dedicated his career to education and chaired the department for two decades, died Nov. 25 in Ithaca. Terzian was 80.

Released: 6-Dec-2019 12:35 PM EST
Has physics ever been deterministic?
University of Vienna

Researchers from the Austrian Academy of Sciences, the University of Vienna and the University of Geneva, have proposed a new interpretation of classical physics without real numbers. This new study challenges the traditional view of classical physics as deterministic.In classical physics it is usually assumed that if we know where an object is and its velocity, we can exactly predict where it will go.

Released: 6-Dec-2019 12:30 PM EST
Microcavities save organic semiconductors from going dark
Cornell University

More and more electronics manufacturers are favoring organic LED displays for smartphones, TVs and computers because they are brighter and offer a greater color range.

2-Dec-2019 11:05 AM EST
Move Over Jules Verne -- Scientists Deploy Ocean Floats to Peer into Earth’s Interior
Acoustical Society of America (ASA)

The release of more than 50 floating sensors, called Mobile Earthquake Recording in Marine Areas by Independent Divers (MERMAIDs), is increasing the number of seismic stations around the planet. Scientists will use them to clarify the picture of the massive mantel plume in the lower mantel lying below the South Pacific Ocean. This effort will also establish one of the most comprehensive overviews of seismic activity across the globe. Frederik Simons will discuss this international effort during the marine seismoacoustics session of the 178th ASA Meeting.

Released: 6-Dec-2019 12:15 PM EST
Multiplexed C dots track cancer cells to improve patient care
Cornell University

For more than a decade, researchers have used glowing nanoparticles called Cornell dots, or C dots, to illuminate cancer cells, target tumors and even induce cell death.

   


close
3.63295